Excellent training in drug development, but no path for career growth - Avis employé Research Fellow Merck

3,0
17 févr. 2012
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Superb colleagues, excellent drug development programs, amazing legacy, competitive compensation, institutional knowledge still high, excellent corporate citizens, overall management has very good intentions

Inconvénients

patent cliff led to panicked decision making, under the heel of Wall Street, post Schering merger led to period of profound consolidation and ultimately down-sizing...few opportunities for professional growth, lacking a clear emerging markets strategy....China still seems like a mystery to upper management

Découvrez plus d’avis sur Merck

5,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Excellent company to work with.

Inconvénients

No cons encountered so far

4,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Inconvénients

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Voir les avis par: Utile|Évaluation|Date|Tout